Advances in antiretroviral therapy. Based on data presented at the 15th Conference on Retroviruses and Opportunistic Infections (CROI), February 3-6, 2008

Research output: Contribution to journalArticle

Abstract

Advances continue to be made in the field of antiretroviral therapy. New agents are progressing through various stages of preclinical and clinical development. New studies add to our understanding of how best to use the antiretroviral agents that are already available for clinical use. This article reports on antiretroviral therapy-related presentations made at the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) which took place on February 3-6, 2008 in Boston, Massachusetts.

Original languageEnglish (US)
Pages (from-to)551-555
Number of pages5
JournalDrugs of the Future
Volume33
Issue number6
StatePublished - Jun 2008

Fingerprint

Retroviridae Infections
Anti-Retroviral Agents
Opportunistic Infections
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Pharmacology

Cite this

@article{de5c555ae60a4b8a99832f2a84ae436a,
title = "Advances in antiretroviral therapy. Based on data presented at the 15th Conference on Retroviruses and Opportunistic Infections (CROI), February 3-6, 2008",
abstract = "Advances continue to be made in the field of antiretroviral therapy. New agents are progressing through various stages of preclinical and clinical development. New studies add to our understanding of how best to use the antiretroviral agents that are already available for clinical use. This article reports on antiretroviral therapy-related presentations made at the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) which took place on February 3-6, 2008 in Boston, Massachusetts.",
author = "Zelalem Temesgen",
year = "2008",
month = "6",
language = "English (US)",
volume = "33",
pages = "551--555",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "6",

}

TY - JOUR

T1 - Advances in antiretroviral therapy. Based on data presented at the 15th Conference on Retroviruses and Opportunistic Infections (CROI), February 3-6, 2008

AU - Temesgen, Zelalem

PY - 2008/6

Y1 - 2008/6

N2 - Advances continue to be made in the field of antiretroviral therapy. New agents are progressing through various stages of preclinical and clinical development. New studies add to our understanding of how best to use the antiretroviral agents that are already available for clinical use. This article reports on antiretroviral therapy-related presentations made at the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) which took place on February 3-6, 2008 in Boston, Massachusetts.

AB - Advances continue to be made in the field of antiretroviral therapy. New agents are progressing through various stages of preclinical and clinical development. New studies add to our understanding of how best to use the antiretroviral agents that are already available for clinical use. This article reports on antiretroviral therapy-related presentations made at the 15th Conference on Retroviruses and Opportunistic Infections (CROI 2008) which took place on February 3-6, 2008 in Boston, Massachusetts.

UR - http://www.scopus.com/inward/record.url?scp=51749093080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749093080&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:51749093080

VL - 33

SP - 551

EP - 555

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 6

ER -